Cargando…
STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo
SIMPLE SUMMARY: Medulloblastoma (MB) is a malignant brain tumor of childhood that occurs in the cerebellum and accounts for 20–25% of all pediatric central nervous system tumors. Despite improvement in overall survival rate, it still lacks an effective targeted treatment strategy. Here, we delineate...
Autores principales: | Rohrer, Kyle A., Song, Heyu, Akbar, Anum, Chen, Yingling, Pramanik, Suravi, Wilder, Phillip J., McIntyre, Erin M., Chaturvedi, Nagendra K., Bhakat, Kishor K., Rizzino, Angie, Coulter, Don W., Ray, Sutapa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136921/ https://www.ncbi.nlm.nih.gov/pubmed/37190167 http://dx.doi.org/10.3390/cancers15082239 |
Ejemplares similares
-
Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment
por: Ray, Sutapa, et al.
Publicado: (2021) -
The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells
por: Pramanik, Suravi, et al.
Publicado: (2022) -
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
por: Kling, Matthew J., et al.
Publicado: (2022) -
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
por: Chaturvedi, Nagendra K., et al.
Publicado: (2019) -
Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells
por: Cox, Jesse L., et al.
Publicado: (2012)